US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvalent, Inc.

84.59

+3.664.52%

Post-market: 86.261.67+1.97%16:50 EDT

Volume:449.57K

Turnover:37.63M

Market Cap:6.07B

PE:-19.20

High:84.75

Open:80.82

Low:80.02

Close:80.93

Loading ...

Overview Company News Filings

Nuvalent Announces Positive Pivotal Data for Zidesamtinib in Lung Cancer

Nuvalent (NUVL) Gets a Buy from Goldman Sachs

Nuvalent Inc. CFO Alexandra Balcom Reports Disposal of Common Shares

Nuvalent’s Promising Biotech Advancements: Buy Rating Backed by Strong Clinical Results

Nuvalent assigned Buy rating, $105 price target at Goldman Sachs

Guggenheim Keeps Their Buy Rating on Nuvalent (NUVL)

Nuvalent Is Maintained at Outperform by Leerink Partners

Nuvalent’s Zidesamtinib: A Promising Blockbuster in the ROS1 Inhibitor Landscape

Nuvalent price target raised to $130 from $110 at H.C. Wainwright

Nuvalent, Inc. : H.c. Wainwright Raises Target Price to $130 From $110

THOMSON REUTERS

Nuvalent’s Zidesamib: Promising Best-in-Class ROS1 TKI with Strong Efficacy and Safety Profile

Nuvalent Inc : Leerink Partners Raises Target Price to $140 From $125

THOMSON REUTERS

Nuvalent Reports Positive Data From Phase 1/2 Trial of Zidesamtinib in Lung Cancer

MT Newswires Live

Nuvalent Announces Positive Data for Zidesamtinib Trial

Nuvalent Inc. Announces FDA's Acceptance of NDA for Zidesamtinib in ROS1-Positive NSCLC Under Real-Time Oncology Review Program

Nuvalent Announces Positive Pivotal Data From Arros-1 Clinical Trial of Zidesamtinib for Tki Pre-Treated Patients With Advanced Ros1-Positive Nsclc

THOMSON REUTERS

Nuvalent Inc - Company Plans to Initiate a Rolling Nda Submission in July 2025 With Target Completion in Q3 of 2025

THOMSON REUTERS

Nuvalent Inc. Announces Upcoming Webcast to Discuss Pivotal Data on Zidesamtinib for Advanced ROS1-positive NSCLC from ARROS-1 Trial

Nuvalent Announces New Director and Annual Meeting Results

Nuvalent Inc. Files Initial Statement of Beneficial Ownership for Director Christy J. Oliger

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NUVL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NUVL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NUVL\",,,,,undefined,":{"symbol":"NUVL","market":"US","secType":"STK","nameCN":"Nuvalent, Inc.","latestPrice":84.59,"timestamp":1752523200000,"preClose":80.93,"halted":0,"volume":449566,"hourTrading":{"tag":"盘后","latestPrice":86.26,"preClose":84.59,"latestTime":"16:50 EDT","volume":21884,"amount":1851570.71,"timestamp":1752526237295},"delay":0,"floatShares":41263836,"shares":71808765,"eps":-4.406658,"marketStatus":"Closed","change":3.66,"latestTime":"07-14 16:00:00 EDT","open":80.82,"high":84.75,"low":80.0201,"amount":37631142.31734,"amplitude":0.058444,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.406658,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1752566400000},"marketStatusCode":5,"adr":0,"listingDate":1627531200000,"exchange":"NASDAQ","adjPreClose":80.93,"postHourTrading":{"tag":"盘后","latestPrice":86.26,"preClose":84.59,"latestTime":"16:50 EDT","volume":21884,"amount":1851570.71,"timestamp":1752526237295},"volumeRatio":0.981524,"impliedVol":0.5073,"impliedVolPercentile":0.524},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NUVL\",,,,,undefined,":{"symbol":"NUVL","floatShares":41263836,"roa":"-22.23%","roe":"-35.69%","lyrEps":-3.926527,"volumeRatio":0.981524,"shares":71808765,"dividePrice":0,"high":84.75,"amplitude":0.058444,"preClose":80.93,"low":80.0201,"week52Low":55.535,"pbRate":"6.01","week52High":113.51,"institutionHeld":0,"latestPrice":84.59,"eps":-4.406658,"divideRate":0,"volume":449566,"delay":0,"ttmEps":-4.406658,"open":80.82,"prevYearClose":78.28,"prevWeekClose":80.93,"prevMonthClose":76.3,"prevQuarterClose":76.3,"fiveDayClose":77.93,"twentyDayClose":77.91,"sixtyDayClose":70.78},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NUVL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2549258564","title":"Nuvalent Announces Positive Pivotal Data for Zidesamtinib in Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2549258564","media":"Insider Monkey","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549258564?lang=en_us&edition=fundamental","pubTime":"2025-07-06 16:00","pubTimestamp":1751788853,"startTime":"0","endTime":"0","summary":"Nuvalent Inc.  is one of the best high short interest stocks with huge upside potential. On June 24, Nuvalent announced positive pivotal data from its global ARROS-1 Phase 1/2 clinical trial for zidesamtinib. The novel ROS1-selective inhibitor is being developed for TKI  pre-treated patients with advanced ROS1-positive non-small cell lung cancer/NSCLC.The company also provided updates on the front-line development strategies for its parallel lead programs in both ROS1-positive and ALK-positive NSCLC. For zidesamtinib, Nuvalent has aligned with the FDA on its NDA submission strategy for TKI pre-treated patients with advanced ROS1-positive NSCLC.A physician standing in a lab, with vials of biopharmaceuticals in hand.The FDA has agreed to accept the NDA for participation in the Real-Time Oncology Review/RTOR pilot program, which allows for earlier submission of topline data to expedite the FDA’s evaluation. Nuvalent plans to initiate a rolling NDA submission this July, with completion tar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nuvalent-announces-positive-pivotal-data-080053663.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","NUVL","BK4539"],"gpt_icon":0},{"id":"2548509823","title":"Nuvalent (NUVL) Gets a Buy from Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2548509823","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548509823?lang=en_us&edition=fundamental","pubTime":"2025-07-04 15:35","pubTimestamp":1751614544,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Richard Law CFA maintained a Buy rating on Nuvalent yesterday. The company’s shares closed yesterday at $80.48. According to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/nuvalent-nuvl-gets-a-buy-from-goldman-sachs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/nuvalent-nuvl-gets-a-buy-from-goldman-sachs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","BK4550","LU1894683348.USD","BK4539","IE0004086264.USD","LU2237443382.USD","BK4504","LU1868837136.USD","LU2471134796.USD","LU0106831901.USD","BK4552","LU2237443549.SGD","CFA","BK4585","LU2750360997.AUD","BK4127","IE0002270589.USD","LU0251142724.SGD","BK4516","BK4588","IE0034235188.USD","LU0742534661.SGD","LU1894683264.USD","LU0251131958.USD","IE00BFXG1179.USD","LU1868836757.USD","LU2471134952.CNY","NUVL","LU2471134523.USD","LU2237438978.USD","LU1868836914.USD","LU1868837300.USD","LU2237443895.HKD","BK4139","LU2237443622.USD","IE00B19Z3581.USD","LU2750360641.GBP","IE0004091025.USD","LU1668664300.SGD","LU0061475181.USD","LU0048573561.USD","IE00BSNM7G36.USD","LU2471134879.HKD","LU0096364046.USD","IE00B19Z3B42.SGD","LU2237443978.SGD","LU2237443465.HKD","LU1868836591.USD","LU1791807156.HKD"],"gpt_icon":0},{"id":"2548377887","title":"Nuvalent Inc. CFO Alexandra Balcom Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2548377887","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548377887?lang=en_us&edition=fundamental","pubTime":"2025-07-02 04:31","pubTimestamp":1751401862,"startTime":"0","endTime":"0","summary":"Alexandra Balcom, the Chief Financial Officer of Nuvalent Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL88qpQN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NUVL","BK4539"],"gpt_icon":0},{"id":"2548010187","title":"Nuvalent’s Promising Biotech Advancements: Buy Rating Backed by Strong Clinical Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2548010187","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548010187?lang=en_us&edition=fundamental","pubTime":"2025-07-01 04:15","pubTimestamp":1751314516,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Richard Law CFA has maintained their bullish stance on NUVL stock, giving a Buy rating on June 25. Richard Law CFA has given ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/nuvalents-promising-biotech-advancements-buy-rating-backed-by-strong-clinical-results-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/nuvalents-promising-biotech-advancements-buy-rating-backed-by-strong-clinical-results-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVL"],"gpt_icon":0},{"id":"2548010193","title":"Nuvalent assigned Buy rating, $105 price target at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2548010193","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548010193?lang=en_us&edition=fundamental","pubTime":"2025-07-01 04:10","pubTimestamp":1751314219,"startTime":"0","endTime":"0","summary":"Goldman Sachs assigned Nuvalent (NUVL) a Buy rating with a $105 price target having previously initiated coverage at Not Rated. Upon the completion...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvalent-assigned-buy-rating-105-price-target-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvalent-assigned-buy-rating-105-price-target-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVL"],"gpt_icon":0},{"id":"2546102712","title":"Guggenheim Keeps Their Buy Rating on Nuvalent (NUVL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2546102712","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546102712?lang=en_us&edition=fundamental","pubTime":"2025-06-25 20:36","pubTimestamp":1750854979,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from Guggenheim reiterated a Buy rating on Nuvalent (NUVL – Research Report), with a price target of $105.00. The c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-nuvalent-nuvl-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-nuvalent-nuvl-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Guggenheim Keeps Their Buy Rating on Nuvalent (NUVL)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVL"],"gpt_icon":0},{"id":"2545239974","title":"Nuvalent Is Maintained at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2545239974","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545239974?lang=en_us&edition=fundamental","pubTime":"2025-06-24 23:14","pubTimestamp":1750778040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NUVL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 24, 2025 11:14 ET (15:14 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL"],"gpt_icon":0},{"id":"2545236366","title":"Nuvalent’s Zidesamtinib: A Promising Blockbuster in the ROS1 Inhibitor Landscape","url":"https://stock-news.laohu8.com/highlight/detail?id=2545236366","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545236366?lang=en_us&edition=fundamental","pubTime":"2025-06-24 22:25","pubTimestamp":1750775112,"startTime":"0","endTime":"0","summary":"Analyst Andrew Berens from Leerink Partners maintained a Buy rating on Nuvalent (NUVL – Research Report) and increased the price target to $140.00 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/nuvalents-zidesamtinib-a-promising-blockbuster-in-the-ros1-inhibitor-landscape-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/nuvalents-zidesamtinib-a-promising-blockbuster-in-the-ros1-inhibitor-landscape-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2545235627","title":"Nuvalent price target raised to $130 from $110 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2545235627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545235627?lang=en_us&edition=fundamental","pubTime":"2025-06-24 22:15","pubTimestamp":1750774511,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Swayampakula Ramakanth raised the firm’s price target on Nuvalent (NUVL) to $130 from $110 and keeps a Buy rating on the sh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvalent-price-target-raised-to-130-from-110-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvalent-price-target-raised-to-130-from-110-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVL"],"gpt_icon":0},{"id":"2545623583","title":"Nuvalent, Inc. : H.c. Wainwright Raises Target Price to $130 From $110","url":"https://stock-news.laohu8.com/highlight/detail?id=2545623583","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545623583?lang=en_us&edition=fundamental","pubTime":"2025-06-24 22:10","pubTimestamp":1750774240,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nAZN40ZW4U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NUVL","BK4539","BK4139"],"gpt_icon":0},{"id":"2545359532","title":"Nuvalent’s Zidesamib: Promising Best-in-Class ROS1 TKI with Strong Efficacy and Safety Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2545359532","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545359532?lang=en_us&edition=fundamental","pubTime":"2025-06-24 22:05","pubTimestamp":1750773913,"startTime":"0","endTime":"0","summary":"In a report released today, Charles Zhu from LifeSci Capital maintained a Buy rating on Nuvalent (NUVL – Research Report), with a price target of $...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/nuvalents-zidesamib-promising-best-in-class-ros1-tki-with-strong-efficacy-and-safety-profile-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/nuvalents-zidesamib-promising-best-in-class-ros1-tki-with-strong-efficacy-and-safety-profile-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVL","BK4139","BK4539"],"gpt_icon":0},{"id":"2545336182","title":"Nuvalent Inc : Leerink Partners Raises Target Price to $140 From $125","url":"https://stock-news.laohu8.com/highlight/detail?id=2545336182","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545336182?lang=en_us&edition=fundamental","pubTime":"2025-06-24 21:59","pubTimestamp":1750773572,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nFWN3SR0QL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NUVL","BK4539"],"gpt_icon":0},{"id":"2545281356","title":"Nuvalent Reports Positive Data From Phase 1/2 Trial of Zidesamtinib in Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2545281356","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545281356?lang=en_us&edition=fundamental","pubTime":"2025-06-24 19:19","pubTimestamp":1750763972,"startTime":"0","endTime":"0","summary":"Nuvalent  reported Tuesday positive data from its phase 1/2 clinical trial of zidesamtinib in tyrosine kinase inhibitor pre-treated patients with advanced ROS1-positive non-small cell lung cancer, or NSCLC.The company said 117 patients under the study demonstrated an objective response rate by blinded independent central review, or ORR by BICR, of 44% with an initial estimated durability of response of 78% at 12 months. A subset of 55 patients had a 51% ORR with an initial estimated durability of response of 93% at year one, the company added.Zidesamtinib also demonstrated intracranial responses and activity against tumors, along with a well-tolerated safety profile, according to Nuvalent.Nuvalent said it plans to start a rolling new drug application for zidesamtinib in July and targets completion in Q3.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4539","NUVL"],"gpt_icon":0},{"id":"2545895982","title":"Nuvalent Announces Positive Data for Zidesamtinib Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2545895982","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545895982?lang=en_us&edition=fundamental","pubTime":"2025-06-24 18:58","pubTimestamp":1750762693,"startTime":"0","endTime":"0","summary":"Nuvalent ( ($NUVL) ) has shared an update. On June 24, 2025, Nuvalent, Inc. announced positive pivotal data for its ROS1-selective inhibitor, zides...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nuvalent-announces-positive-data-for-zidesamtinib-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nuvalent-announces-positive-data-for-zidesamtinib-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2545286633","title":"Nuvalent Inc. Announces FDA's Acceptance of NDA for Zidesamtinib in ROS1-Positive NSCLC Under Real-Time Oncology Review Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2545286633","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545286633?lang=en_us&edition=fundamental","pubTime":"2025-06-24 18:36","pubTimestamp":1750761361,"startTime":"0","endTime":"0","summary":"Nuvalent Inc. Announces FDA's Acceptance of NDA for Zidesamtinib in ROS1-Positive NSCLC Under Real-Time Oncology Review Program. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 24, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nNDLbSbbwf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2545286885","title":"Nuvalent Announces Positive Pivotal Data From Arros-1 Clinical Trial of Zidesamtinib for Tki Pre-Treated Patients With Advanced Ros1-Positive Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2545286885","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545286885?lang=en_us&edition=fundamental","pubTime":"2025-06-24 18:30","pubTimestamp":1750761034,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nFWN3SR0H6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2545286342","title":"Nuvalent Inc - Company Plans to Initiate a Rolling Nda Submission in July 2025 With Target Completion in Q3 of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2545286342","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545286342?lang=en_us&edition=fundamental","pubTime":"2025-06-24 18:30","pubTimestamp":1750761034,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nFWN3SR0H6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2545447779","title":"Nuvalent Inc. Announces Upcoming Webcast to Discuss Pivotal Data on Zidesamtinib for Advanced ROS1-positive NSCLC from ARROS-1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2545447779","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545447779?lang=en_us&edition=fundamental","pubTime":"2025-06-24 04:30","pubTimestamp":1750710628,"startTime":"0","endTime":"0","summary":"Nuvalent Inc. Announces Upcoming Webcast to Discuss Pivotal Data on Zidesamtinib for Advanced ROS1-positive NSCLC from ARROS-1 Trial. Nuvalent Inc., a clinical-stage biopharmaceutical company specializing in targeted cancer therapies, has announced that it will present pivotal data from its global ARROS-1 Phase 1/2 clinical trial. This data pertains to zidesamtinib, a novel ROS1-selective inhibitor, tested in TKI pre-treated patients with advanced ROS1-positive non-small cell lung cancer. The presentation of the study results is scheduled for June 24, 2025, at 8:00 a.m. ET during a webcast and conference call hosted by the company. Interested parties can access the event through the Nuvalent website, with a replay and slides available for 30 days post-event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nNDLjxzD6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2545802103","title":"Nuvalent Announces New Director and Annual Meeting Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2545802103","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545802103?lang=en_us&edition=fundamental","pubTime":"2025-06-21 05:20","pubTimestamp":1750454407,"startTime":"0","endTime":"0","summary":"Nuvalent ( ($NUVL) ) has issued an update. On June 18, 2025, Nuvalent, Inc. announced the election of Christy J. Oliger as a Class III director and...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nuvalent-announces-new-director-and-annual-meeting-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nuvalent-announces-new-director-and-annual-meeting-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","NUVL"],"gpt_icon":0},{"id":"2545083851","title":"Nuvalent Inc. Files Initial Statement of Beneficial Ownership for Director Christy J. Oliger","url":"https://stock-news.laohu8.com/highlight/detail?id=2545083851","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545083851?lang=en_us&edition=fundamental","pubTime":"2025-06-21 04:32","pubTimestamp":1750451533,"startTime":"0","endTime":"0","summary":"Nuvalent Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Christy J. Oliger as a Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 20, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nNDL5tQ1M6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","BK4139","BK4539"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NUVL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"NUVL","fiscalQuarterEnding":"2025/03","expectedEps":-1.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-1.18},{"market":"US","date":"2021-09-08","symbol":"NUVL","fiscalQuarterEnding":"2021/06","expectedEps":-0.21,"name":null,"time":"","type":"earning","dateTimestamp":1631073600000,"reportTimeType":"","actualEps":-3.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NUVL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NUVL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3846,"buy":0.6154,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6154,"analysts":13,"updateTime":1751342400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NUVL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NUVL","date":"2025-07-11","current":-19.588592,"percent":0.735751,"low":-69.351693,"twenty":-36.000722,"median":-25.992618,"eighty":-17.808028,"high":-6.26114,"avg":-27.068989,"sd":10.988594,"marketCap":5893345343},"quantilePoints":[{"date":"2021-07-30","current":-32.003439,"twenty":-32.354161,"median":-30.636831,"eighty":-29.270224,"marketCap":854491809},{"date":"2021-08-06","current":-39.893047,"twenty":-43.683429,"median":-39.621789,"eighty":-30.910153,"marketCap":1065144356},{"date":"2021-08-13","current":-40.471731,"twenty":-41.958227,"median":-39.504244,"eighty":-32.529523,"marketCap":1080595226},{"date":"2021-08-20","current":-48.862653,"twenty":-46.591318,"median":-40.471731,"eighty":-36.252451,"marketCap":1304632842},{"date":"2021-08-27","current":-62.732992,"twenty":-50.544455,"median":-43.437488,"eighty":-38.56569,"marketCap":1674970884},{"date":"2021-09-03","current":-68.881512,"twenty":-60.248267,"median":-45.860729,"eighty":-39.075655,"marketCap":1839136379},{"date":"2021-09-10","current":-65.348412,"twenty":-63.759706,"median":-47.741452,"eighty":-39.480734,"marketCap":1828513906},{"date":"2021-09-17","current":-62.94983,"twenty":-64.761708,"median":-50.860923,"eighty":-39.730292,"marketCap":1761399189},{"date":"2021-09-24","current":-39.44718,"twenty":-64.530478,"median":-49.278583,"eighty":-39.730292,"marketCap":1103771531},{"date":"2021-10-01","current":-41.63869,"twenty":-64.170784,"median":-47.714326,"eighty":-39.410891,"marketCap":1165092171},{"date":"2021-10-08","current":-31.371379,"twenty":-63.759706,"median":-45.860729,"eighty":-38.543989,"marketCap":877802556},{"date":"2021-10-15","current":-34.391176,"twenty":-63.187962,"median":-44.468269,"eighty":-35.519718,"marketCap":962299502},{"date":"2021-10-22","current":-34.529224,"twenty":-62.863095,"median":-42.812096,"eighty":-35.340256,"marketCap":966162219},{"date":"2021-10-29","current":-42.156369,"twenty":-62.364081,"median":-41.897529,"eighty":-36.171994,"marketCap":1179577362},{"date":"2021-11-05","current":-50.180402,"twenty":-61.727974,"median":-42.812096,"eighty":-36.430833,"marketCap":1404097818},{"date":"2021-11-12","current":-34.028754,"twenty":-60.644972,"median":-42.648165,"eighty":-36.184709,"marketCap":1212410461},{"date":"2021-11-19","current":-33.039467,"twenty":-58.433025,"median":-41.63869,"eighty":-35.340256,"marketCap":1177163164},{"date":"2021-11-26","current":-27.740684,"twenty":-57.008396,"median":-40.965706,"eighty":-34.418786,"marketCap":988372845},{"date":"2021-12-03","current":-27.063091,"twenty":-55.474121,"median":-40.006605,"eighty":-33.154505,"marketCap":964230860},{"date":"2021-12-10","current":-29.08232,"twenty":-53.340223,"median":-39.44718,"eighty":-32.23948,"marketCap":1036173974},{"date":"2021-12-17","current":-30.952478,"twenty":-52.342712,"median":-39.01578,"eighty":-31.220564,"marketCap":1102805851},{"date":"2021-12-23","current":-26.0467,"twenty":-51.940512,"median":-38.554839,"eighty":-29.461772,"marketCap":928017884},{"date":"2021-12-31","current":-25.802767,"twenty":-50.991433,"median":-38.204749,"eighty":-29.258494,"marketCap":919326769},{"date":"2022-01-07","current":-19.785735,"twenty":-50.180402,"median":-37.074482,"eighty":-28.635108,"marketCap":704945947},{"date":"2022-01-14","current":-17.210879,"twenty":-49.278583,"median":-36.755246,"eighty":-27.835548,"marketCap":613206406},{"date":"2022-01-21","current":-16.723012,"twenty":-48.945839,"median":-36.461894,"eighty":-27.290762,"marketCap":595824177},{"date":"2022-01-28","current":-17.590331,"twenty":-48.274083,"median":-36.023835,"eighty":-26.393628,"marketCap":626725917},{"date":"2022-02-04","current":-19.528249,"twenty":-47.81855,"median":-34.8916,"eighty":-26.000624,"marketCap":695771993},{"date":"2022-02-11","current":-24.325612,"twenty":-47.698051,"median":-34.304828,"eighty":-25.474811,"marketCap":866697243},{"date":"2022-02-18","current":-24.108782,"twenty":-47.445386,"median":-33.614657,"eighty":-24.726748,"marketCap":858971808},{"date":"2022-02-25","current":-21.018955,"twenty":-46.753363,"median":-32.880245,"eighty":-23.908215,"marketCap":748884359},{"date":"2022-03-04","current":-20.463328,"twenty":-46.073478,"median":-32.376852,"eighty":-22.116657,"marketCap":729087931},{"date":"2022-03-11","current":-21.005403,"twenty":-45.876805,"median":-31.765591,"eighty":-21.612527,"marketCap":748401519},{"date":"2022-03-18","current":-16.289352,"twenty":-45.336102,"median":-31.130443,"eighty":-21.013534,"marketCap":580373307},{"date":"2022-03-25","current":-17.102464,"twenty":-44.94676,"median":-29.461772,"eighty":-20.382017,"marketCap":609343688},{"date":"2022-04-01","current":-15.39984,"twenty":-44.68041,"median":-29.270224,"eighty":-19.994434,"marketCap":713597794},{"date":"2022-04-08","current":-13.710758,"twenty":-44.217879,"median":-29.08232,"eighty":-18.704295,"marketCap":635329113},{"date":"2022-04-14","current":-12.397028,"twenty":-43.553225,"median":-28.729971,"eighty":-18.145958,"marketCap":574453471},{"date":"2022-04-22","current":-11.343958,"twenty":-42.840121,"median":-28.228552,"eighty":-17.273218,"marketCap":525656330},{"date":"2022-04-29","current":-10.728799,"twenty":-42.680951,"median":-27.835548,"eighty":-17.086202,"marketCap":497151070},{"date":"2022-05-06","current":-10.926901,"twenty":-42.353087,"median":-27.38156,"eighty":-16.790771,"marketCap":506330730},{"date":"2022-05-13","current":-6.7688,"twenty":-41.949297,"median":-26.954676,"eighty":-16.549548,"marketCap":386512008},{"date":"2022-05-20","current":-6.819566,"twenty":-41.526351,"median":-26.487136,"eighty":-16.27309,"marketCap":389410848},{"date":"2022-05-27","current":-7.987184,"twenty":-41.200988,"median":-26.0467,"eighty":-15.742753,"marketCap":456084169},{"date":"2022-06-03","current":-7.775659,"twenty":-40.866911,"median":-26.033148,"eighty":-14.722122,"marketCap":444005669},{"date":"2022-06-10","current":-7.919496,"twenty":-40.401417,"median":-25.836647,"eighty":-13.721184,"marketCap":452219049},{"date":"2022-06-17","current":-8.477922,"twenty":-40.07474,"median":-25.545281,"eighty":-12.528401,"marketCap":484106290},{"date":"2022-06-24","current":-11.498499,"twenty":-39.893047,"median":-24.827032,"eighty":-12.282337,"marketCap":656587273},{"date":"2022-07-01","current":-11.464655,"twenty":-39.621789,"median":-24.09523,"eighty":-11.740163,"marketCap":654654713},{"date":"2022-07-08","current":-15.39902,"twenty":-39.482102,"median":-23.614139,"eighty":-11.765186,"marketCap":879314818},{"date":"2022-07-15","current":-14.121409,"twenty":-39.398794,"median":-22.27928,"eighty":-11.796764,"marketCap":806360676},{"date":"2022-07-22","current":-12.903025,"twenty":-39.172792,"median":-21.750757,"eighty":-11.911231,"marketCap":736788515},{"date":"2022-07-29","current":-12.573046,"twenty":-38.953658,"median":-21.547478,"eighty":-12.213523,"marketCap":717946054},{"date":"2022-08-05","current":-13.613749,"twenty":-38.669722,"median":-21.018955,"eighty":-12.041695,"marketCap":777372276},{"date":"2022-08-12","current":-12.344485,"twenty":-38.522289,"median":-20.829229,"eighty":-12.041695,"marketCap":811402986},{"date":"2022-08-19","current":-11.814173,"twenty":-38.3924,"median":-20.361689,"eighty":-12.011358,"marketCap":776545578},{"date":"2022-08-26","current":-11.593209,"twenty":-38.23687,"median":-20.124532,"eighty":-11.962731,"marketCap":762021658},{"date":"2022-09-02","current":-12.337119,"twenty":-37.455071,"median":-19.873822,"eighty":-11.913447,"marketCap":810918855},{"date":"2022-09-09","current":-12.955817,"twenty":-37.250109,"median":-19.121693,"eighty":-11.888628,"marketCap":851585830},{"date":"2022-09-16","current":-13.022106,"twenty":-37.041696,"median":-18.281477,"eighty":-11.956614,"marketCap":855943006},{"date":"2022-09-23","current":-12.35185,"twenty":-36.880877,"median":-17.841041,"eighty":-11.986524,"marketCap":811887116},{"date":"2022-09-30","current":-14.318424,"twenty":-36.797586,"median":-17.305742,"eighty":-12.008096,"marketCap":941150003},{"date":"2022-10-07","current":-13.684996,"twenty":-36.724185,"median":-17.197327,"eighty":-12.034926,"marketCap":899514766},{"date":"2022-10-14","current":-15.268566,"twenty":-36.558528,"median":-17.07536,"eighty":-12.071402,"marketCap":1003602858},{"date":"2022-10-21","current":-14.649869,"twenty":-36.430833,"median":-16.885634,"eighty":-12.126467,"marketCap":962935882},{"date":"2022-10-28","current":-26.02948,"twenty":-36.184709,"median":-16.736563,"eighty":-12.171497,"marketCap":1710917752},{"date":"2022-11-04","current":-26.315342,"twenty":-36.021716,"median":-16.933065,"eighty":-12.236034,"marketCap":1729707455},{"date":"2022-11-11","current":-24.734689,"twenty":-35.340256,"median":-17.102464,"eighty":-12.277734,"marketCap":1806127008},{"date":"2022-11-18","current":-23.845786,"twenty":-34.8916,"median":-17.231207,"eighty":-12.315206,"marketCap":1741219318},{"date":"2022-11-25","current":-24.927929,"twenty":-34.74665,"median":-17.380277,"eighty":-12.340065,"marketCap":1820237375},{"date":"2022-12-02","current":-27.849714,"twenty":-34.474005,"median":-18.091751,"eighty":-12.347431,"marketCap":2033586128},{"date":"2022-12-09","current":-23.96946,"twenty":-34.322098,"median":-18.484755,"eighty":-12.360689,"marketCap":1750249953},{"date":"2022-12-16","current":-22.856399,"twenty":-34.14259,"median":-19.528249,"eighty":-12.383179,"marketCap":1668974238},{"date":"2022-12-23","current":-21.982955,"twenty":-33.863115,"median":-19.989013,"eighty":-12.401198,"marketCap":1605195378},{"date":"2022-12-30","current":-23.01872,"twenty":-33.499619,"median":-20.151635,"eighty":-12.411064,"marketCap":1680826946},{"date":"2023-01-06","current":-21.526909,"twenty":-33.039467,"median":-20.361689,"eighty":-12.425505,"marketCap":1571894911},{"date":"2023-01-13","current":-25.067062,"twenty":-32.880245,"median":-20.692113,"eighty":-12.43287,"marketCap":1830396839},{"date":"2023-01-20","current":-23.868975,"twenty":-32.667097,"median":-20.829229,"eighty":-12.43287,"marketCap":1742912562},{"date":"2023-01-27","current":-25.09025,"twenty":-32.607408,"median":-21.018955,"eighty":-12.454243,"marketCap":1832090083},{"date":"2023-02-03","current":-23.242878,"twenty":-32.23948,"median":-21.295022,"eighty":-12.497137,"marketCap":1697194972},{"date":"2023-02-10","current":-22.160736,"twenty":-32.032331,"median":-21.41483,"eighty":-12.512417,"marketCap":1618176916},{"date":"2023-02-17","current":-25.144358,"twenty":-31.813161,"median":-21.547478,"eighty":-12.561215,"marketCap":1836040986},{"date":"2023-02-24","current":-23.258337,"twenty":-31.529064,"median":-21.655893,"eighty":-12.61268,"marketCap":1698323802},{"date":"2023-03-03","current":-23.150123,"twenty":-31.258268,"median":-21.825291,"eighty":-12.655311,"marketCap":1690421996},{"date":"2023-03-10","current":-20.483415,"twenty":-31.11996,"median":-21.77786,"eighty":-12.694101,"marketCap":1495698928},{"date":"2023-03-17","current":-21.066674,"twenty":-31.002698,"median":-21.750757,"eighty":-12.767298,"marketCap":1724391538},{"date":"2023-03-24","current":-19.133888,"twenty":-30.058054,"median":-21.655893,"eighty":-12.828665,"marketCap":1566185277},{"date":"2023-03-31","current":-18.073973,"twenty":-29.453641,"median":-21.544923,"eighty":-12.858593,"marketCap":1479427005},{"date":"2023-04-06","current":-16.335159,"twenty":-29.377022,"median":-21.488261,"eighty":-12.867431,"marketCap":1337098075},{"date":"2023-04-14","current":-19.85701,"twenty":-29.270224,"median":-21.3442,"eighty":-12.881669,"marketCap":1625375676},{"date":"2023-04-21","current":-23.2682,"twenty":-29.265532,"median":-21.362124,"eighty":-12.924142,"marketCap":1904595240},{"date":"2023-04-28","current":-23.815932,"twenty":-29.188024,"median":-21.526909,"eighty":-12.97644,"marketCap":1949429276},{"date":"2023-05-04","current":-25.759189,"twenty":-29.047085,"median":-21.547478,"eighty":-13.010321,"marketCap":2108492618},{"date":"2023-05-12","current":-25.430668,"twenty":-28.87091,"median":-21.684156,"eighty":-13.022106,"marketCap":2275968472},{"date":"2023-05-19","current":-24.709927,"twenty":-28.710998,"median":-21.777538,"eighty":-13.036805,"marketCap":2211464368},{"date":"2023-05-26","current":-24.551205,"twenty":-28.635108,"median":-21.836093,"eighty":-13.095599,"marketCap":2197259175},{"date":"2023-06-02","current":-26.982834,"twenty":-28.385754,"median":-21.975225,"eighty":-13.131082,"marketCap":2414882725},{"date":"2023-06-09","current":-26.976485,"twenty":-28.315219,"median":-21.998414,"eighty":-13.150094,"marketCap":2414314517},{"date":"2023-06-16","current":-28.366895,"twenty":-28.315219,"median":-22.102764,"eighty":-13.18266,"marketCap":2538752003},{"date":"2023-06-23","current":-26.709832,"twenty":-28.306861,"median":-22.335952,"eighty":-13.208307,"marketCap":2390449793},{"date":"2023-06-30","current":-27.198697,"twenty":-28.268754,"median":-22.446731,"eighty":-13.258915,"marketCap":2434201786},{"date":"2023-07-07","current":-25.414655,"twenty":-28.133689,"median":-22.531756,"eighty":-13.410685,"marketCap":2274535423},{"date":"2023-07-14","current":-26.627296,"twenty":-28.013291,"median":-22.709537,"eighty":-13.436068,"marketCap":2383063093},{"date":"2023-07-21","current":-28.538315,"twenty":-28.133689,"median":-22.767353,"eighty":-13.469912,"marketCap":2554093611},{"date":"2023-07-28","current":-29.477953,"twenty":-28.312487,"median":-22.83321,"eighty":-13.57127,"marketCap":2638188351},{"date":"2023-08-04","current":-28.862109,"twenty":-28.557674,"median":-22.893801,"eighty":-13.610321,"marketCap":2583072204},{"date":"2023-08-11","current":-24.764415,"twenty":-28.557674,"median":-23.065098,"eighty":-13.658962,"marketCap":2479438043},{"date":"2023-08-18","current":-23.414561,"twenty":-28.426575,"median":-23.157853,"eighty":-13.68205,"marketCap":2344289281},{"date":"2023-08-25","current":-23.824644,"twenty":-28.373244,"median":-23.263269,"eighty":-13.705606,"marketCap":2385347133},{"date":"2023-09-01","current":-25.954793,"twenty":-28.336421,"median":-23.39747,"eighty":-13.749072,"marketCap":2598619862},{"date":"2023-09-08","current":-26.99139,"twenty":-28.32557,"median":-23.414561,"eighty":-13.761194,"marketCap":2702404987},{"date":"2023-09-15","current":-27.338821,"twenty":-28.315219,"median":-23.555926,"eighty":-13.769146,"marketCap":2737190112},{"date":"2023-09-22","current":-24.587852,"twenty":-28.305414,"median":-23.621628,"eighty":-13.830806,"marketCap":2461760356},{"date":"2023-09-29","current":-26.518657,"twenty":-28.280196,"median":-23.696285,"eighty":-13.88343,"marketCap":2655074408},{"date":"2023-10-06","current":-35.546163,"twenty":-28.305414,"median":-23.77622,"eighty":-13.903115,"marketCap":3558917393},{"date":"2023-10-13","current":-34.236178,"twenty":-28.379593,"median":-23.8154,"eighty":-13.955573,"marketCap":3427760367},{"date":"2023-10-20","current":-29.064584,"twenty":-28.744733,"median":-23.845786,"eighty":-14.026646,"marketCap":2909975237},{"date":"2023-10-27","current":-33.614382,"twenty":-28.862109,"median":-23.861246,"eighty":-14.053721,"marketCap":3365505501},{"date":"2023-11-03","current":-34.337138,"twenty":-29.211299,"median":-23.903358,"eighty":-14.060633,"marketCap":3437868548},{"date":"2023-11-10","current":-35.464886,"twenty":-29.44822,"median":-23.947665,"eighty":-14.060633,"marketCap":3550779854},{"date":"2023-11-17","current":-31.866939,"twenty":-29.833491,"median":-23.964282,"eighty":-14.121409,"marketCap":3634424412},{"date":"2023-11-24","current":-34.755447,"twenty":-30.824236,"median":-23.993876,"eighty":-14.178851,"marketCap":3963858712},{"date":"2023-12-01","current":-35.89767,"twenty":-31.144585,"median":-24.054485,"eighty":-14.230533,"marketCap":4094129310},{"date":"2023-12-08","current":-38.896007,"twenty":-31.669705,"median":-24.123342,"eighty":-14.266938,"marketCap":4436089628},{"date":"2023-12-15","current":-43.38253,"twenty":-31.894239,"median":-24.22903,"eighty":-14.297696,"marketCap":4947777505},{"date":"2023-12-22","current":-38.720281,"twenty":-32.410785,"median":-24.257295,"eighty":-14.315478,"marketCap":4416047998},{"date":"2023-12-29","current":-41.224386,"twenty":-32.610609,"median":-24.317291,"eighty":-14.330209,"marketCap":4701641231},{"date":"2024-01-05","current":-39.862504,"twenty":-32.805979,"median":-24.337125,"eighty":-14.347886,"marketCap":4546318596},{"date":"2024-01-12","current":-40.768595,"twenty":-33.028713,"median":-24.382811,"eighty":-14.347886,"marketCap":4649658252},{"date":"2024-01-19","current":-40.362227,"twenty":-33.4798,"median":-24.425506,"eighty":-14.383306,"marketCap":4603311982},{"date":"2024-01-26","current":-41.899836,"twenty":-34.069015,"median":-24.465511,"eighty":-14.439543,"marketCap":4778676248},{"date":"2024-02-02","current":-42.657657,"twenty":-34.347946,"median":-24.545441,"eighty":-14.462864,"marketCap":4865105779},{"date":"2024-02-09","current":-44.25018,"twenty":-34.775757,"median":-24.580747,"eighty":-14.478998,"marketCap":5046733055},{"date":"2024-02-16","current":-46.402832,"twenty":-34.95921,"median":-24.709927,"eighty":-14.504403,"marketCap":5292243027},{"date":"2024-02-23","current":-45.705417,"twenty":-35.262302,"median":-24.734689,"eighty":-14.556028,"marketCap":5212702806},{"date":"2024-03-01","current":-42.698561,"twenty":-35.546163,"median":-24.77209,"eighty":-14.598111,"marketCap":5389369708},{"date":"2024-03-08","current":-42.363551,"twenty":-36.021716,"median":-24.804256,"eighty":-14.610096,"marketCap":5347085067},{"date":"2024-03-15","current":-42.942205,"twenty":-36.558528,"median":-24.831986,"eighty":-14.622658,"marketCap":5420122174},{"date":"2024-03-22","current":-40.373794,"twenty":-36.868914,"median":-24.992974,"eighty":-14.641549,"marketCap":5095939926},{"date":"2024-03-28","current":-38.90178,"twenty":-37.200741,"median":-25.005225,"eighty":-14.658707,"marketCap":4910143776},{"date":"2024-04-05","current":-36.495798,"twenty":-37.374818,"median":-25.061735,"eighty":-14.675345,"marketCap":4606463172},{"date":"2024-04-12","current":-34.516193,"twenty":-37.267525,"median":-25.09025,"eighty":-14.735959,"marketCap":4356599384},{"date":"2024-04-19","current":-32.008693,"twenty":-37.255768,"median":-25.199563,"eighty":-14.847142,"marketCap":4040105252},{"date":"2024-04-26","current":-33.536542,"twenty":-37.200741,"median":-25.298949,"eighty":-14.916986,"marketCap":4232948842},{"date":"2024-05-03","current":-37.038357,"twenty":-37.101882,"median":-25.381429,"eighty":-14.992892,"marketCap":4674944398},{"date":"2024-05-10","current":-29.955741,"twenty":-36.987234,"median":-25.430668,"eighty":-15.077502,"marketCap":4358829897},{"date":"2024-05-17","current":-32.227266,"twenty":-36.898587,"median":-25.520776,"eighty":-15.184387,"marketCap":4689357283},{"date":"2024-05-24","current":-29.583069,"twenty":-36.872823,"median":-25.569485,"eighty":-15.320748,"marketCap":4304602748},{"date":"2024-05-31","current":-29.494337,"twenty":-36.839925,"median":-25.653696,"eighty":-15.399184,"marketCap":4291691522},{"date":"2024-06-07","current":-36.206872,"twenty":-36.753783,"median":-25.749363,"eighty":-15.460497,"marketCap":5268425769},{"date":"2024-06-14","current":-35.040054,"twenty":-36.747932,"median":-25.822877,"eighty":-15.703127,"marketCap":5098643147},{"date":"2024-06-21","current":-34.782732,"twenty":-36.712369,"median":-25.874326,"eighty":-15.710732,"marketCap":5061200592},{"date":"2024-06-28","current":-34.148302,"twenty":-36.661942,"median":-25.890823,"eighty":-15.727693,"marketCap":4968885326},{"date":"2024-07-05","current":-31.965508,"twenty":-36.495798,"median":-25.923936,"eighty":-15.787932,"marketCap":4651269166},{"date":"2024-07-12","current":-34.600833,"twenty":-36.461894,"median":-25.988967,"eighty":-15.815036,"marketCap":5034732578},{"date":"2024-07-15","current":-34.893647,"twenty":-36.45154,"median":-26.009223,"eighty":-15.833901,"marketCap":5077339624},{"date":"2024-08-02","current":-33.815559,"twenty":-36.441187,"median":-26.02948,"eighty":-15.852766,"marketCap":4920468228},{"date":"2024-08-09","current":-26.219913,"twenty":-36.38746,"median":-26.039924,"eighty":-15.936679,"marketCap":4551383634},{"date":"2024-08-16","current":-26.843308,"twenty":-36.294826,"median":-26.091487,"eighty":-16.068186,"marketCap":4659595631},{"date":"2024-08-23","current":-30.983098,"twenty":-36.163411,"median":-26.131203,"eighty":-16.227286,"marketCap":5378201049},{"date":"2024-08-30","current":-31.916324,"twenty":-36.072704,"median":-26.182617,"eighty":-16.27309,"marketCap":5540195056},{"date":"2024-09-06","current":-31.714747,"twenty":-36.030193,"median":-26.219913,"eighty":-16.289352,"marketCap":5505204350},{"date":"2024-09-13","current":-30.490355,"twenty":-36.010736,"median":-26.305926,"eighty":-16.294773,"marketCap":5292668213},{"date":"2024-09-20","current":-41.470105,"twenty":-36.185141,"median":-26.404281,"eighty":-16.320196,"marketCap":7198588141},{"date":"2024-09-27","current":-41.023082,"twenty":-36.489017,"median":-26.487136,"eighty":-16.335438,"marketCap":7120991681},{"date":"2024-10-04","current":-42.063985,"twenty":-36.839925,"median":-26.521016,"eighty":-16.36506,"marketCap":7301676910},{"date":"2024-10-11","current":-41.629121,"twenty":-37.123057,"median":-26.535236,"eighty":-16.487703,"marketCap":7226190975},{"date":"2024-10-18","current":-41.519389,"twenty":-37.41054,"median":-26.571994,"eighty":-16.548812,"marketCap":7207143122},{"date":"2024-10-25","current":-38.052666,"twenty":-38.109047,"median":-26.647191,"eighty":-16.659123,"marketCap":6605372068},{"date":"2024-10-31","current":-36.674918,"twenty":-38.085179,"median":-26.68862,"eighty":-16.674608,"marketCap":6366215694},{"date":"2024-11-08","current":-38.239617,"twenty":-38.115014,"median":-26.712656,"eighty":-16.695908,"marketCap":6637823966},{"date":"2024-11-15","current":-28.56865,"twenty":-38.204749,"median":-26.80059,"eighty":-16.723012,"marketCap":6407519770},{"date":"2024-11-22","current":-29.37648,"twenty":-38.115014,"median":-26.887601,"eighty":-16.736563,"marketCap":6588703796},{"date":"2024-11-29","current":-30.627824,"twenty":-38.091146,"median":-26.954676,"eighty":-16.844978,"marketCap":6869361404},{"date":"2024-12-06","current":-29.693276,"twenty":-38.059169,"median":-26.97966,"eighty":-16.893765,"marketCap":6659756355},{"date":"2024-12-13","current":-27.504216,"twenty":-37.747042,"median":-27.063091,"eighty":-16.953393,"marketCap":6168783172},{"date":"2024-12-20","current":-26.813601,"twenty":-37.583519,"median":-27.063095,"eighty":-17.053677,"marketCap":6013888593},{"date":"2024-12-27","current":-25.996268,"twenty":-37.492453,"median":-26.987112,"eighty":-17.091622,"marketCap":5830572991},{"date":"2025-01-03","current":-25.340501,"twenty":-37.40921,"median":-26.975395,"eighty":-17.134988,"marketCap":5683494194},{"date":"2025-01-10","current":-24.789276,"twenty":-37.336436,"median":-26.943787,"eighty":-17.189196,"marketCap":5559862741},{"date":"2025-01-17","current":-24.073317,"twenty":-37.267588,"median":-26.849001,"eighty":-17.21901,"marketCap":5399283958},{"date":"2025-01-24","current":-26.515813,"twenty":-37.267337,"median":-26.813601,"eighty":-17.251535,"marketCap":5947099188},{"date":"2025-01-31","current":-27.798837,"twenty":-37.238414,"median":-26.828454,"eighty":-17.305742,"marketCap":6234862052},{"date":"2025-02-07","current":-27.466201,"twenty":-37.144232,"median":-26.880129,"eighty":-17.454813,"marketCap":6160256865},{"date":"2025-02-14","current":-25.644625,"twenty":-37.038357,"median":-26.846155,"eighty":-17.471277,"marketCap":5751704651},{"date":"2025-02-21","current":-26.100811,"twenty":-36.968696,"median":-26.785736,"eighty":-17.56652,"marketCap":5854020336},{"date":"2025-02-28","current":-20.411984,"twenty":-36.918696,"median":-26.712656,"eighty":-17.605929,"marketCap":5322547194},{"date":"2025-03-07","current":-20.027736,"twenty":-36.886624,"median":-26.694963,"eighty":-17.787173,"marketCap":5222352284},{"date":"2025-03-14","current":-20.450586,"twenty":-36.865624,"median":-26.667087,"eighty":-17.99777,"marketCap":5332613081},{"date":"2025-03-21","current":-21.318253,"twenty":-36.86125,"median":-26.590122,"eighty":-18.067045,"marketCap":5558862508},{"date":"2025-03-28","current":-20.214449,"twenty":-36.776416,"median":-26.54476,"eighty":-18.073973,"marketCap":5271038870},{"date":"2025-04-04","current":-18.759184,"twenty":-36.749395,"median":-26.523364,"eighty":-18.088195,"marketCap":4891569894},{"date":"2025-04-11","current":-17.021104,"twenty":-36.712369,"median":-26.515813,"eighty":-17.99777,"marketCap":4438355060},{"date":"2025-04-17","current":-19.212238,"twenty":-36.686342,"median":-26.48036,"eighty":-18.046198,"marketCap":5009706462},{"date":"2025-04-25","current":-20.313297,"twenty":-36.567446,"median":-26.420448,"eighty":-18.064693,"marketCap":5296814121},{"date":"2025-05-02","current":-20.931098,"twenty":-36.475456,"median":-26.315342,"eighty":-18.073973,"marketCap":5457909441},{"date":"2025-05-09","current":-17.089596,"twenty":-36.430833,"median":-26.28219,"eighty":-18.073973,"marketCap":5141507574},{"date":"2025-05-16","current":-16.946387,"twenty":-36.395868,"median":-26.219913,"eighty":-17.80499,"marketCap":5098422315},{"date":"2025-05-23","current":-17.478647,"twenty":-36.366622,"median":-26.183178,"eighty":-17.602029,"marketCap":5258555860},{"date":"2025-05-30","current":-17.84383,"twenty":-36.316227,"median":-26.173393,"eighty":-17.576984,"marketCap":5368423271},{"date":"2025-06-06","current":-18.638639,"twenty":-36.238974,"median":-26.132081,"eighty":-17.5849,"marketCap":5607546458},{"date":"2025-06-13","current":-18.595677,"twenty":-36.163411,"median":-26.113701,"eighty":-17.59813,"marketCap":5594620881},{"date":"2025-06-20","current":-18.027615,"twenty":-36.085461,"median":-26.070805,"eighty":-17.639806,"marketCap":5423716020},{"date":"2025-06-27","current":-18.886868,"twenty":-36.030193,"median":-26.0467,"eighty":-17.760818,"marketCap":5682227574},{"date":"2025-07-03","current":-19.209088,"twenty":-36.013239,"median":-26.033148,"eighty":-17.765211,"marketCap":5779169407},{"date":"2025-07-11","current":-19.588592,"twenty":-36.000722,"median":-25.992618,"eighty":-17.808028,"marketCap":5893345343}],"updateTime":1752509508131}}}